| Board | Date | Title | Result | Stage |
|---|---|---|---|---|
| Board of Optometry | 05/06/2021 | Addition of investigational drug to TPA formulary | Take no action | |
| Board of Optometry | 12/05/2017 | Inactive licensure | Initiate a regulatory change | Final |
| Board of Optometry | 10/31/2017 | Inclusion of the National Glaucoma Society as approved provider of CE | Take no action | |
| Board of Optometry | 02/13/2012 | Informed consent prior to treatment | Take no action | |
| Board of Optometry | 12/18/2009 | Practice adjacent to mercantile establishment | Take no action | |
| Board of Optometry | 03/07/2016 | Requirement for optometrist to provide patient's pupillary distance to consumer | Take no action | |
| Board of Optometry | 04/22/2020 | Restriction on number of contact lenses per prescription | Take no action |